Tonga Healthcare Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tonga Healthcare Daily.

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

Press releases published on March 9, 2026

Mar. 9, 2026

Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock

GlobeNewswire

Mar. 9, 2026

Coherus Oncology Reports Full Year and Fourth Quarter 2025 Financial Results and Provides Business Update

GlobeNewswire

Mar. 9, 2026

Bionano to Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call Webcast on March 23, 2026

GlobeNewswire

Mar. 9, 2026

AEON Biopharma Appoints John Bencich as Chief Financial Officer

GlobeNewswire

Mar. 9, 2026

Septerna Highlights Pipeline Progress and Reports Fourth Quarter and Full Year 2025 Financial Results

GlobeNewswire

Mar. 9, 2026

Ardelyx Announces Publication of a Review Article Demonstrating Rapid and Meaningful Symptom Relief with Tenapanor in IBS-C

GlobeNewswire

Mar. 9, 2026

CapsoVision to Participate in the 38th Annual ROTH Conference

GlobeNewswire

Mar. 9, 2026

Lifecore Biomedical to Report Financial Results for the Fourth Quarter and Transition Period Ended December 31, 2025, on March 16, 2026

GlobeNewswire

Mar. 9, 2026

Zevra Reports Fourth Quarter and Full Year 2025 Financial Results

GlobeNewswire

Mar. 9, 2026

LifeMD Reports Fourth Quarter and Full Year 2025 Results

GlobeNewswire

Mar. 9, 2026

Alpha Tau Announces Full Year 2025 Financial Results and Provides Corporate Update

GlobeNewswire

Mar. 9, 2026

Voyager Reports Fourth Quarter and Full Year 2025 Financial and Operating Results

GlobeNewswire

Mar. 9, 2026

Aquestive Therapeutics Announces Grant of Inducement Award Pursuant to Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Mar. 9, 2026

Design Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Updates

GlobeNewswire

Mar. 9, 2026

C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Mar. 9, 2026

Stereotaxis Reports 2025 Full Year Financial Results

GlobeNewswire

Mar. 9, 2026

MacroGenics Reports 2025 Financial Results and Highlights Upcoming Planned Data Disclosures

GlobeNewswire

Mar. 9, 2026

Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Mar. 9, 2026

Xenon Pharmaceuticals Announces Proposed Public Offering

GlobeNewswire

Mar. 9, 2026

Dianthus Therapeutics, Inc. Announces Proposed $400 Million Underwritten Public Offering

GlobeNewswire